Skip to main content
Log in

Analysing rising economic burden of renal cell carcinoma in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Shih YT, et al. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data. PharmacoEconomics : 8 Jul 2019. Available from: URL: http://doi.org/10.1007/s40273-019-00824-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Analysing rising economic burden of renal cell carcinoma in USA. PharmacoEcon Outcomes News 833, 8 (2019). https://doi.org/10.1007/s40274-019-6072-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6072-6

Navigation